Sort   by:  
 Page size 
UnknownLinking two randomised controlled trials for Healthy Beginnings©: optimising early obesity prevention programs for children under 3 years.
Not available
S-EPMC6567558 | biostudies-literature
UnknownIntravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials.
Not available
S-EPMC10600726 | biostudies-literature
UnknownAssessing the impact of a self-guided digital intervention for fear of cancer recurrence (iConquerFear) in ovarian cancer survivors: a pilot randomised waitlist-controlled trial.
Not available
S-EPMC11929991 | biostudies-literature
ProteomicsGlobal Protein Abundance and Phosphorylation Analyses of Influenza A Virus (IAV)-Infected Human Cells
Influenza A Virus (IAV) is a recurring respiratory virus with antiviral therapies of limited use. Understanding host proteins essential for IAV infection can identify targets for alternative host-directed therapies (HDTs). Using affinity purification-mass spectrometry and global phosphoproteomic and...
ORGANISM(S): Homo sapiens (Human) 
2023-07-25 | PXD035900 | Pride
Human H5n1 H1n1 Protein abundance Phosphorylation Nhbe H3n2 Thp-1 Infection Influenza a virus 
UnknownDeformable templates guided discriminative models for robust 3D brain MRI segmentation.
Not available
S-EPMC5966025 | biostudies-literature
UnknownA course-based research experience: how benefits change with increased investment in instructional time.
Not available
S-EPMC3940452 | biostudies-literature
UnknownAn international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes.
Not available
S-EPMC7719087 | biostudies-literature
UnknownATXN2 trinucleotide repeat length correlates with risk of ALS.
Not available
S-EPMC5302215 | biostudies-literature
UnknownPenetrance of Hemochromatosis in HFE Genotypes Resulting in p.Cys282Tyr and p.[Cys282Tyr];[His63Asp] in the eMERGE Network.
Not available
S-EPMC4596892 | biostudies-literature
UnknownCompassionate access to virus-specific T cells for adoptive immunotherapy over 15 years.
Not available
S-EPMC11615211 | biostudies-literature
Sort   by:  
 Page size